Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Inbal

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|April 13, 1991
Warfarin antagonism by avocadoD Blickstein, M Shaklai, A Inbal
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophiliaH Carp, M Dolitzky, A Inbal
Israel Journal of Medical Sciences|December 1, 1978
A retrospective study of patients with chronic myeloid leukemia diagnosed and treated at the Chaim Sheba Medical Center during the years 1966-76A Inbal, M Modan, A Many
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1991
Haemarthrosis in patients with mild coagulation factor deficiencyO Bairey, M Shaklai, A Inbal
Journal of Thrombosis and Haemostasis : JTH|September 1, 2005
Factor XIII (FXIII) and angiogenesisR Dardik, J Loscalzo, A Inbal
The Journal of Clinical Investigation|October 1, 1986
von Willebrand protein facilitates platelet incorporation in polymerizing fibrinJ Loscalzo, A Inbal, R I Handin
Israel Journal of Medical Sciences|June 1, 1982
Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative diseaseR Lang, A Inbal, I Jutrin, et al.
Acta Haematologica|January 1, 1985
A therapeutic trial with low-dose cytarabine in myelodysplastic syndromes and acute leukemiaA Inbal, E Januszewicz, M Rabinowictz, et al.
Acta Haematologica|January 1, 1985
Persistent lymphocytosis: an unusual feature in sarcoidosisA Inbal, I Avidor, L Nemesh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2015
Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand diseaseR Shaikh-Zaidi, A Lubetsky, A Inbal, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|April 13, 1991
Warfarin antagonism by avocadoD Blickstein, M Shaklai, A Inbal
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophiliaH Carp, M Dolitzky, A Inbal
Israel Journal of Medical Sciences|December 1, 1978
A retrospective study of patients with chronic myeloid leukemia diagnosed and treated at the Chaim Sheba Medical Center during the years 1966-76A Inbal, M Modan, A Many
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1991
Haemarthrosis in patients with mild coagulation factor deficiencyO Bairey, M Shaklai, A Inbal
Journal of Thrombosis and Haemostasis : JTH|September 1, 2005
Factor XIII (FXIII) and angiogenesisR Dardik, J Loscalzo, A Inbal
The Journal of Clinical Investigation|October 1, 1986
von Willebrand protein facilitates platelet incorporation in polymerizing fibrinJ Loscalzo, A Inbal, R I Handin
Israel Journal of Medical Sciences|June 1, 1982
Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative diseaseR Lang, A Inbal, I Jutrin, et al.
Acta Haematologica|January 1, 1985
A therapeutic trial with low-dose cytarabine in myelodysplastic syndromes and acute leukemiaA Inbal, E Januszewicz, M Rabinowictz, et al.
Acta Haematologica|January 1, 1985
Persistent lymphocytosis: an unusual feature in sarcoidosisA Inbal, I Avidor, L Nemesh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2015
Pharmacokinetic profile of Optivate® (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand diseaseR Shaikh-Zaidi, A Lubetsky, A Inbal, et al.
Pageof 7